The effects of polysulfonate derivative (GL 2021) on coagulation in vitro and thrombosis in vivo.
Radziwon
P
P
Department of Haematology, Medical Academy of Bialystok, Bialystok, Poland. pmrsmok@amb.ac.bialystok.pl
Schenk
J
J
Boczkowska-Radziwon
B
B
Wojtukiewicz
M Z
MZ
Giedrojc
J
J
Kloczko
J
J
Breddin
H K
HK
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001160:Arterioles / Q000187:drug effects / Q000473:pathology; D001777:Blood Coagulation / Q000187:drug effects*; D003094:Collagen / Q000494:pharmacology; D004195:Disease Models, Animal; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007834:Lasers / Q000009:adverse effects; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects / Q000473:pathology; D010314:Partial Thromboplastin Time; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D011108:Polymers / Q000494:pharmacology*; D011517:Prothrombin Time; D051381:Rats; D017208:Rats, Wistar; D013451:Sulfonic Acids / Q000494:pharmacology*; D013918:Thrombin Time; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control
D000925:Anticoagulants; D005343:Fibrinolytic Agents; C103634:GL 2021; D011108:Polymers; D013451:Sulfonic Acids; D000244:Adenosine Diphosphate; D003094:Collagen